Clinical Trial Update: Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial estimating the ED95 of intrathecal hyperbaric prilocaine 2% with sufentanyl for scheduled cesarean delivery has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Delivery
• Pregnant Women

Drugs mentioned

• Prilocaine (prilocaine)
• Sufentanyl (sufentanil)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Pregnant Women | Phase 2 | Status: COMPLETED | Results posted: 2020-04-20